Loading clinical trials...
Loading clinical trials...
Randomized, Double-Blind, 2x2 Factorial Trial of Remimazolam vs. Midazolam on Sedation and Early Cognitive Outcomes in Patients Undergoing Traumatic or Non-Traumatic Orthopedic Surgery With Regional Anesthesia
Conditions
Interventions
Midazolam
REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]
Locations
1
Romania
Clinical Emergency Hospital of Bucharest
Bucharest, Romania
Start Date
October 1, 2025
Primary Completion Date
January 1, 2026
Completion Date
February 15, 2026
Last Updated
October 1, 2025
NCT07327463
NCT05036538
NCT07186426
NCT07231926
NCT05595954
NCT07145619
Lead Sponsor
Romanian Society for Enteral and Parenteral Nutrition
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions